Table 2.
Baseline Clinical Characteristic of the Study Populations
| Trial | Stduy Duration, mo | Sample Size, No. | CPAP Patients, No. | Antihypertensive Drugs at Baseline | Antihypertensive drugs (Mean±SD), No. | CPAP Pressure (Mean±SD), cm/H2O | CPAP Compliance (Mean±SD), h/Night | Mean Age, y | Male, % | BMI (Mean±SD), kg/m2 | AHI (Mean±SD), No./night | ESS (Mean±SD), No. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lloberes et al20 | 3 | 58 | 29 | Yes | NR | 9.6±1.5 | 5.7±1.5 | 58.7±9.5 | 72.4 | 32.0±4.9 | 50.0±20.3 | 7.3±4 |
| Martinez‐Garcia et al19 | 3 | 194 | 98 | Yes | 3.7±0.9 | 8.5±2.1 | 5±1.9 | 56.0±9.5 | 68.6 | 34.1±5.4 | 40.4 ±18.9 | 9.1±3.7 |
| Pedrosa et al18 | 6 | 35 | 19 | Yes | 4 (4–5)a | 11.5±0.5 | 6.02±0.33 | 56±1 | 77.0 | 32 (28–39)b | 29 (24–48)c | 10±1 |
| Duran‐Cantolla et al16 | 3 | 340 | 169 | No | 0 | 8.8±1.6 | 4.5±1.7 | 53.2±10.2 | 79.0 | 31.9±5.7 | 44.5±24.6 | 10.3±4.2 |
| Lozano et al17 | 3 | 64 | 29 | Yes | 3.41±0.57 | 9.62±1.54 | 5.6±1.52 | 59.2±9.9 | 75.9 | 30.8±5 | 52.67±21.5 | 6.14±3.30 |
| Campos‐Rodriguez et al14 | 1 | 68 | 34 | Yes | 2.0±0.9 | 9.5±1.9 | 5.0±1.4 | 55.3±9.6 | 55.8 | 35.7±5.6 | 58.3±24.6 | 15.0±3.9 |
| Robinson et al13 | 1 | 35 | 18 | Yes | NR | 10.4±1.5 | 5.2±2.1 | 54±8 | 88.6 | 33.2±5.3 | 28.1 (18.0–38.0) | 5.3 (3.0–7.0)d |
Abbreviations: CPAP, continuous positive airway pressure; NR, not reported; SD, standard deviation. aRepresenting the mean number of antihypertensive drugs and 95% confidence interval. bRepresenting the mean baseline body mass index (BMI) and 95% confidence interval. cRepresenting the mean baseline apnea hypopnea index (AHI) and 95% confidence interval. dRepresenting the mean baseline Epworth Sleepiness Scale (ESS) and 95% confidence interval.